Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

8.08
+2.6247.99%
Post-market: 7.82-0.2600-3.22%19:59 EST
Volume:75.53M
Turnover:612.32M
Market Cap:64.28M
PE:-1.51
High:9.83
Open:7.00
Low:6.94
Close:5.46
52wk High:30.22
52wk Low:3.44
Shares:7.96M
Float Shares:3.39M
Volume Ratio:989.08
T/O Rate:2228.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3568
EPS(LYR):-6.6216
ROE:-302.55%
ROA:-21.12%
PB:-37.33
PE(LYR):-1.22

Loading ...

Biodesix Inc expected to post a loss of $1.44 a share - Earnings Preview

Reuters
·
Nov 01, 2025

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

GlobeNewswire
·
Oct 30, 2025

Bio-Rad Laboratories (BIO): Evaluating Valuation After Major Oncology Diagnostics Partnership Expansion with Biodesix

Simply Wall St.
·
Oct 25, 2025

Biodesix expands partnership agreement with Bio-Rad

TIPRANKS
·
Oct 22, 2025

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

GlobeNewswire
·
Oct 22, 2025

Biodesix Inc : TD Cowen Adjusts Target Price to $40 From $2 to Reflect Reverse Stock Split

THOMSON REUTERS
·
Oct 21, 2025

Biodesix Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 20, 2025

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

GlobeNewswire
·
Oct 15, 2025

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

GlobeNewswire
·
Oct 06, 2025

Biodesix Regains Nasdaq Compliance with Bid Price

TIPRANKS
·
Oct 02, 2025

Director’s Bold Move: Massive Biodesix Stock Purchase Unveiled!

TIPRANKS
·
Sep 24, 2025

Director and 10% Owner Jack W. Schuler Reports Acquisition of Common Shares in Biodesix Inc

Reuters
·
Sep 24, 2025

Director Makes Bold Move with Major Biodesix Stock Purchase

TIPRANKS
·
Sep 20, 2025

Biodesix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 20, 2025

Biodesix price target lowered to $20 from $30 at Canaccord

TIPRANKS
·
Sep 19, 2025

Biodesix Inc. Announces 1-for-20 Reverse Stock Split and Bylaw Amendments

Reuters
·
Sep 16, 2025

Biodesix trading halted, news pending

TIPRANKS
·
Sep 13, 2025

Biodesix Inc. Announces 1-for-20 Reverse Stock Split Effective September 15, 2025

Reuters
·
Sep 11, 2025

Biodesix Announces One-for-Twenty Reverse Stock Split

THOMSON REUTERS
·
Sep 11, 2025

Biodesix Inc. to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth Conference

Reuters
·
Sep 05, 2025